預填充式注射器市場規模、佔有率、成長分析，按類型、按設計、按材料、按應用、按地區 - 行業預測，2024-2031 年

2022年全球預填充式注射器市場規模將為68億美元，從2023年的75.2億美元成長到2031年的168.4億美元，預測期間（2024-2031年）預計複合年成長率為10.60%。

預填充式注射器市場的成長主要是由於對高效且方便用戶使用的給藥系統的需求不斷成長以及醫療保健專業人員為減少醫院錯誤而做出的努力所推動的。促成這一市場擴張的因素包括居家醫療服務的增加、注射藥物使用的增加、慢性病患病率的增加以及預填充式注射器相對於傳統管瓶的優勢。預填充式注射器的技術進步在支援市場成長方面也發揮著重要作用。然而，它面臨著替代醫療保健提供方法的可用性、嚴格的政府法規和產品召回等挑戰，這可能會阻礙市場擴張。相反，生技藥品和生物相似藥的發展，以及預填充注射劑需求的不斷成長，為該行業的未來成長提供了良好的機會。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價格分析
• 價值鏈分析
• 市場生態系統
• 貿易分析
• 供應鏈分析
• 案例研究分析
• 專利分析
• 客戶和購買標準分析
• 監管環境
• 創新矩陣
• 重點投資分析
• 關鍵成功因素
• 競爭程度

預填充式注射器市場：依類型

• 市場概況
• 傳統預填充式注射器
  • 一次性預填充式注射器
  • 可重複使用的預填充式注射器
• 安全預填充式注射器

預填充式注射器市場：設計

• 市場概況
• 單室預填充式注射器
• 雙腔室預填充式注射器
• 客製化預填充式注射器

預填充式注射器市場：依材料分類

• 市場概況
• 玻璃預填充式注射器
• 塑膠預填充式注射器

預填充式注射器市場：依應用分類

• 市場概況
• 糖尿病
• 類風濕性關節炎
• 過敏反應
• 癌症
• 血栓症
• 眼科
• 其他

預填充式注射器市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• BD（US）
• Gerresheimer AG（Germany）
• SCHOTT（Germany）
• West Pharmaceutical Services, Inc.（US）
• AptarGroup, Inc.（US）
• Nipro（Japan）
• Baxter（Simtra）（US）
• Owen Mumford Ltd.（UK）
• Weigao Medical International Co., Ltd.（China）
• Credence MedSystems, Inc.（US）
• Novartis AG（Switzerland）
• Stevanato Group（Italy）
• Poly Medicure（India）
• MedXL Inc.（Canada）
• Sharps Technology, Inc.（US）
• Fresenius Kabi USA（US）
• Medefil, Inc.（US）
• DBMSRL（Italy）
• Taisei Kako Co., Ltd.（Japan）
• Shandong Province Medicinal Glass Co., Ltd.（China）
• Shin Yan Sheno Precision Industrial Co., Ltd.（Taiwan）
• JO Pharma Co., Ltd.（Otsuka Holdings Co., Ltd.）（Japan）
• BMI Korea（South Korea）
• Al Shifa Medical Products Co.（Saudi Arabia）

Global Prefilled Syringes Market size was valued at USD 6.8 billion in 2022 and is poised to grow from USD 7.52 billion in 2023 to USD 16.84 billion by 2031, growing at a CAGR of 10.60% during the forecast period (2024-2031).

The growth of the prefilled syringes market is primarily driven by increasing demand for efficient and user-friendly drug delivery systems, coupled with efforts by healthcare professionals to reduce hospital errors. Factors contributing to this market expansion include the rise in home healthcare services, the growing use of injectable medications, the higher prevalence of chronic diseases, and the benefits of prefilled syringes compared to traditional vials. Technological advancements in prefilled syringes also play a crucial role in supporting market growth. However, the market faces challenges such as the availability of alternative medicine delivery methods, stringent government regulations, and product recalls, which may hinder its expansion. Conversely, the development of biologics and biosimilars, along with the increasing demand for injectable medications in prefilled formats, offer promising opportunities for future growth in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Prefilled Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Prefilled Syringes Market Segmental Analysis

Global Prefilled Syringes Market is segmented by Type, Design, Material, Application, and region. Based on Type, the market is segmented into Conventional Prefilled Syringes, and Safety Prefilled Syringes. Based on Design, the market is segmented into Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes. Based on Material, the market is segmented into Glass Prefilled Syringes, and Plastic Prefilled Syringes. Based on Application, the market is segmented into Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Prefilled Syringes Market

Prefilled syringes are commonly utilized for managing chronic conditions, enabling patients to self-administer their medications for diseases such as diabetes, heart disorders, and autoimmune conditions. The growing global prevalence of these chronic and life-threatening diseases is driving an expansion in the prefilled syringes market. Additionally, the increasing demand for self-injection devices is fueled by their convenience and safety, further contributing to the market's growth.

Restraints in the Global Prefilled Syringes Market

Global growth in the prefilled syringes market faces significant challenges, including product recalls, potential reactions between drugs and syringe components, and other related issues. A notable example occurred, when Novartis Pharmaceuticals UK recalled a batch of Lucentis 10 mg/ml injection solution due to a defect in the plunger stopper. This recall resulted in an uptick in customer complaints regarding difficulties in operating the plunger.

Market Trends of the Global Prefilled Syringes Market

Biologics and biosimilars are increasingly taking the place of chemical-based drugs in the global life science market. These biologics are favored for their targeted delivery capabilities and lower risk of drug interactions, leading to a growing preference for their use. Consequently, pharmaceutical and packaging manufacturers face pressure to innovate and develop advanced container closure and drug delivery systems. This shift has significantly boosted the adoption of prefilled syringes designed for the safe administration of biologics and biosimilars. For example, the Central Drugs Standard Control Organization (CDSCO) in India has approved 98 biosimilars to date, reflecting the expanding use and acceptance of these advanced treatments.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Prefilled Syringes Market by Type

• Market Overview
• Conventional Prefilled Syringes
  • Disposable Prefilled Syringes
  • Reusable Prefilled Syringes
• Safety Prefilled Syringes

Prefilled Syringes Market by Design

• Market Overview
• Single-chamber Prefilled Syringes
• Dual-chamber Prefilled Syringes
• Customized Prefilled Syringes

Prefilled Syringes Market by Material

• Market Overview
• Glass Prefilled Syringes
• Plastic Prefilled Syringes

Prefilled Syringes Market by Application

• Market Overview
• Diabetes
• Rheumatoid Arthritis
• Anaphylaxis
• Cancer
• Thrombosis
• Ophthalmology
• Others

Prefilled Syringes Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• BD (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCHOTT (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter (Simtra) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weigao Medical International Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Credence MedSystems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poly Medicure (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedXL Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharps Technology, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi USA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medefil, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• D.B.M. S.R.L. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taisei Kako Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Province Medicinal Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shin Yan Sheno Precision Industrial Co., Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.O. Pharma Co., Ltd. (Otsuka Holdings Co., Ltd.) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMI Korea (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Al Shifa Medical Products Co. (Saudi Arabia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments